Cite
HARVARD Citation
Tenshin, H. et al. (2022). TGF‐β‐activated kinase‐1 inhibitor LL‐Z1640‐2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF‐α and RANKL expression. Clinical & translational immunology. 11 (1), p. n/a. [Online].